Lumexa Imaging initiated with an Overweight at KeyBanc
Upside potential from overweight rating.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential from overweight rating.
What happened, with direct paths to the underlying reporting
KeyBanc initiates LMRI with Overweight; target 18; current price 9.88.
Target: $18
Posted price: $9.88
Analyst firm: KeyBanc
Analyst: Matthew Gillmor
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.